Skip to main content

Vulnerable Pakistanis to get priority for Chinese COVID-19 vaccine


By Masood Sattar Khan
(Pakistan News & Features Services)

China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement.

The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. 

According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19.

Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. 

In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, had expressed the hope that a successful clinical trial in Pakistan will make it one of the first few countries for the launch of a Covid-19 vaccine. 

The NIH official was then reported to have stated that although clearances were needed for the purpose, the collaboration could be a great thing for Pakistan. Meanwhile, researchers have said that Sinopharm’s coronavirus vaccine candidate appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials. 

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval. 

Sinopharm is testing the potential vaccine in the United Arab Emirates (UAE) in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site. 

The shot did not cause any serious side effects, according to a paper published in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes. The results were based on data from 320 healthy adults in Phase 1 and 2 trials. 

Sinopharm’s chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months. 

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world. China is leading the development of at least eight vaccine candidates in different stages of clinical trials.
Labels:

Comments

Post a Comment

Popular posts from this blog

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more

China’s top advisory body meets

By Masood Sattar Khan (Pakistan News & Features Services) The third annual session of the 13th National Committee of the Chinese People's Political Consultative Conference (CPPCC) opened on May 21, after being delayed for more than two months because of the COVID-19 pandemic. Much is expected of this year's session of China's top political advisers as the country's goal of building a moderately prosperous society in all aspects is expected to be realized by the end of this year, which is also the final year of the country's 13th Five-Year Plan (2016-20).  The CPPCC National Committee gathers the country's smartest minds from different walks of life.  Their ideas have contributed a great deal to what this country has achieved in its endeavors in poverty alleviation, in making progress in all fields for the realization of the goal of building China into a moderately prosperous country in all aspects. And so have their inputs into the fight against the novel co...
Post a Comment
Read more

Railways annual sports gala kickoff at Lahore on June 4

By Abdul Qadir Qureshi (Pakistan News & Features Services) Shoaib Adil, General Manager of Railways’ Welfare and Special Initiatives and President Pakistan Railways Sports Board, has described sports as world’s most powerful moral and social power whose utility and importance has always been in every era since the ancient eras.  He made these observations on the eve of Railways annual sports gala which start from June 4 at the Railways Sports Complex located in Lahore’s Garhi Shahu. He pointed out that while food, work and comfort were the necessities of life, sports were like a pillar which guaranteed the strength and stability of life. “In every part of the world, people of all ages, gender and all status of life have been participating in sports whether collectively or individually,” he stressed.  Shoaib Adil observed that in today’s era, while mobile phone or the smartphone was the source of wide relations and acquisition of knowledge, it had affected the human health ...
Post a Comment
Read more